AB009. Targeting the stratification of neuroblastoma: clinical and biological challenges.

Background Neuroblastoma(NB) is a solid tumor derived from the sympathoadrenal lineage of the neural crest, and is one of the lowest survival rates in pediatric Vietnamesepatients. This is a complex types of cancer because clinical features and genetic diversity heterogeneous. The NB treatment is mostly determined by clinical and biological assessment to classify the patients with low- and high-risk under the guideline of SOPIEN/ COGprotocols.